Evaluation of therapeutic effect of thumbtack needle on high altitude insomnia

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Insomnia was diagnosed according to the insomnia disorder standard of the fifth edition of the diagnostic and Statistical Manual of mental diseases (DSM-V); 2. insomniac group inclusion criteria: ? Patients with insomnia as the main complaint, who meet the above diagnostic criteria and have typical symptom groups of insomnia; ? PSQI = 8 points; ? Age = 18 years old; ? They volunteered to participate in this study and signed informed consent.

•? Those who combine with diseases that have not been effectively controlled or are extremely serious, such as persistent pain, malignant tumors, cardiovascular and cerebrovascular diseases, neuroendocrine diseases, neuromuscular diseases and digestive tract diseases caused by various reasons, resulting in insomnia disorders; Comorbid personality disorder or mental retardation; ? Those with severe depression and anxiety (SAS > 70; Self rating Depression Scale (SDS)>73); ? Use alcohol and / or other drugs or dependent drugs; ? Have suffered from depression or other mental diseases within 6 months before enrollment; ? Those who were treated with insomnia drugs within 1 month before enrollment; ? Those who participated in any other clinical trial within 1 month before baseline; ? Pregnant and lactating patients. ? Those who cannot cooperate with the treatment.

发起方

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences